Evidence map›Paper›PMID 23397390›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2013

Assessment of CD4(+) and CD8 (+) T cell responses using MHC class I and II tetramers.

Sema Kurtulus, David Hildeman

Abstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sema KurtulusDivision of Immunobiology, Department of Pediatrics, University of Cincinnati, Cincinnati, OH, USA.
David Hildeman

Funding

Homeostasis and function of regulatory T cells in agingR01AG033057 · NIA · CINCINNATI CHILDRENS HOSP MED CTR · PI CHOUGNET, CLAIRE A., HILDEMAN, DAVID A · 2009 to 2018
$3.5M
Regulation of Apoptosis in Activated Primary T CellsR01AI057753 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI HILDEMAN, DAVID A · 2005 to 2013
$2.8M
Control of Diabetes by Manipulation of Bc12 Family MembersR01DK081175 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI HILDEMAN, DAVID A, KATZ, JONATHAN DAVID · 2011 to 2014
$1.4M
Regulation of necrotic cell death by protein kinase A and cylindromatosisR21AI088502 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CHAN, FRANCIS KAMING · 2010 to 2011
$450k
Regualtion of Apoptosis in Activated Primary T CellsR56AI057753 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI HILDEMAN, DAVID A · 2008 to 2008
$375k
NIAID NIH HHS AI088502NIAID NIH HHS R01 AI057753NIAID NIH HHS R56 AI057753NIA NIH HHS R01 AG033057NIDDK NIH HHS DK081175NIDDK NIH HHS R01 DK081175
6 · The paper itself

Abstract

The low frequency of T cells specific for given antigens makes the study of antigen-specific T cell responses difficult. The development of MHC class I and II tetramer staining techniques allows precise quantification and tracking of antigen-specific CD8(+) and CD4(+) T cell responses. Here, we describe a protocol for MHC class I and II tetramer staining of mouse T cells isolated from various tissues of mice infected with lymphocytic choriomeningitis virus (LCMV) or with murine cytomegalovirus (MCMV).

Indexed as

Protein MultimerizationAnimalsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell SeparationChlorocebus aethiopsCross ReactionsHistocompatibility Antigens Class IHistocompatibility Antigens Class IILymphocytic choriomeningitis virusMiceMice, Inbred C57BLMuromegalovirusProtein Structure, QuaternarySpleenStaining and LabelingHistocompatibility Antigens Class IHistocompatibility Antigens Class II

Identifiers

PMID23397390
PMCPMC4265237

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.